VasoCare blood treatment data

VSOGF announced initial results of a double-blind, placebo-controlled trial of VasoCare, showing 51 percent improvement

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE